NCT03811340 is a clinical trial in Female Patient Preference, sponsored by TriHealth Inc..

Who is sponsoring NCT03811340?

NCT03811340 is sponsored by TriHealth Inc..

What condition does NCT03811340 study?

NCT03811340 studies Female Patient Preference.

Is NCT03811340 still recruiting?

NCT03811340 is currently completed. Last updated 1 September 2023.

Are results published for NCT03811340?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-09-01 · How we verify

NCT03811340

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Female Patient Preferences Regarding Physician Gender

Completed Results posted Last updated 1 September 2023

What this trial tests

trial in Female Patient Preference in 1,015 participants. Completed in 6 May 2019.

Timeline

5 February 2019

Primary endpoint
6 March 2019

6 May 2019

Quick facts

Lead sponsor	TriHealth Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,015
Start date	5 February 2019
Primary completion	6 March 2019
Estimated completion	6 May 2019
Sites	1 location across United States

Conditions studied

Female Patient Preference — all drugs for Female Patient Preference →

Sponsor

TriHealth Inc. — full company profile →

Who can join

Adults 18 to 80, female only, with Female Patient Preference. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the OB/GYN Care Primary · During a 10 minute period of completing the survey electronically

Proportion of female respondents whose responses are "Male physician" or "Female physician" over "No preference" for the question 15, "For my obstetrician/gynecologist, overall I would prefer a..."

Female physician

Group	Value	95% CI
Survey Population	667

Male physician

Group	Value	95% CI
Survey Population	87

No preference

Group	Value	95% CI
Survey Population	261

Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the Primary Care Physician Primary · During a 10 minute period of completing the survey electronically

Proportion of female respondents whose responses are "Male physician" or "Female physician" over "No preference" for the question 16, "For my primary care physician, overall I would prefer a..."

Female physician preferred

Group	Value	95% CI
Survey Population	473

Male physician preferred

Group	Value	95% CI
Survey Population	102

No preference

Group	Value	95% CI
Survey Population	440

Sponsor's own description

This is a cross sectional survey study to describe female patient preferences when choosing their OB/GYN and other providers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other TriHealth Inc. trials

Trials by the same sponsor.

NCT07017920 — Vitamin D and Hypertensive Disorders of Pregnancy · NA · not yet recruiting
NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
NCT06958003 — Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime · NA · enrolling by invitation
NCT06957990 — Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics · NA · enrolling by invitation
NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03811340 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TriHealth Inc.
Last refreshed: 1 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03811340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing